Nutromics News & Views
Nutromics raise US$7 million and Dr Chris Roberts AO joins Board of Directors as Non-Executive Chairperson
Diagnostics company Nutromics has raised A$11 million ($7 million) ahead of its Series A funding round later this year.
Beyond good ideas: How purpose and grit shape and drive start-up success in health care
In my experience, success relies on two critical factors: purpose and grit to fulfill said purpose.
Chris Roberts backs medtech start-up Nutromics as it raises $11m
Melbourne medical technology start-up, Nutromics, is developing a patch capable of measuring how the body responds to different medications. The company has raised $11m as it looks to build an advanced manufacturing facility and to raise a further $50m.
Biosensing Technology: Where Is the Field Headed?
Biosensors are commonly used in healthcare to monitor a broad range of conditions, including glucose monitoring, pregnancy status, and COVID status. This article explores the science behind DNA-based biosensing and its practical applications in the field of healthcare and biomedical monitoring.
Could DNA-based sensors transform how we look at diagnostics?
Imagine if there was a device that had the capability of identifying early biomarkers of disease, transforming our healthcare system from reactive to proactive, and eventually preventative.
Can Aptamers In Wearable Sensors Mean A Revolution In Healthcare?
How can there be a revolution in wearable sensors, I hear you ask, when the field still seems so nascent?
In Her Own Words: Rosie Stramandinoli protects her team, its intellectual property
Protecting intellectual property, especially with the advent of AI, is challenging; Rosie Stramandinoli believes leaders must be just as vigilant about protecting their team members.
Nutromics Is Revolutionising Healthcare One Patch at a Time
Peter Vranes and his co-founder Hitesh Mehta are on a journey to help people live healthier lives.
Nutromics raises US$14 million for its ground-breaking wearable
Nutromics raised US $14 million from strategic investors Dexcom Ventures, VU Venture Partners, and Artesian Investments.
Balancing the Grind with Peter Vranes, Co-Founder and Co-CEO of Nutromics
In this article, Peter discusses how he maintains a work-life balance, and what this means to him.
The Growing Role for Female Leadership in MedTech Startups: Rosie Stramandinoli
Rosie shares her own journey to becoming a patent attorney, and how shedid not let her circumstances or others deter her in her path.
From Challenging Social Norms to Pursuing Your Vision: Learning from Nutromics Co-Founder Hitesh Mehta
In this article, Hitesh speaks of his calling and vision to create a better, more equitable healthcare system.
Nutromics scores $5.7M as Artesian buys in for third time
This article announces the closing of a new investor round for Nutromics with Artesian buying into the company for a third time with $5.7M.
A Look at the Australian MedTech Market
Nutromics Head of Biosensors, Rob Batchelor, writes of 3 important lessons Australia can learn from the U.S. when it comes to MedTech start-up support.
Sophie Stocker receives grant to lead charge for precision medicineresearch
This article highlights University of Sydney senior lecturer Dr. Sophie Stocker who received Ramaciotti Health Investment Grant of close to $100,000 for precision medical research using a wearable sensor.
Nutromics won in the category of ‘Technology Platform Solution of the Year’ at the AIIA’s 2021 national iAwards!
Nutromics announces the company’s win of Technology Platform Solution of the Year at the AIIA’s 2021 National iAwards, Australia’s longest runningand most broadly scoped innovation recognition program.
Disrupting Diagnostics: DNA-based Sensors and the Future of Healthcare
According to the U.S. Centers for Disease Control and Prevention, 70% of all medical decisions doctors make are based on lab diagnostics.
Lab-on-a-Patch Enables Continuous and Real-Time Monitoring of Multiple Disease Biomarkers
CGMs are incapable of measuring any diagnostic target other than glucose. Now, DNA-based sensing has emerged as a breakthrough technology that overcomes this limitation with its ability to enable continuous and real-time measurements of any diagnostic target.
A patch for every patient
Lab on a Patch utilizes microneedles coated with synthetic DNA-based sensors that measure intended targets in interstitial fluid and communicates via Bluetooth with hospital information systems.
Higher Ed Leaders Join Nutromics Biosensor Advisory Board
Plaxco, who is recognized by Thomson Reuters as one of the most highly cited chemists in the world, has co-authored more than 250 papers and a dozen patents on protein folding, protein dynamics, and folding-based sensors.
Our Podcasts
Talking Precision Medicine by Genialis
In this episode of Talking Precision Medicine, Genialis CEO Rafael Rosengarten sat down with Peter and Hitesh to discuss Nutromics. Nutromics is developing a next generation lab-on-skin, a wearable device for continuous monitoring of health-critical biomarkers.
The Medical Management Podcast
In this 2-part episode, Peter shares his entrepreneurship journey, and how entrepreneurship and uncertainty have taught him to be a better person. He also talks about the need for continuous monitoring and how Nutromics’ wearables will transform healthcare.
The Artesian Podcast
In this Artesian Podcast episode, a part of the ArteHouse Innovation Series, Peter and Hitesh discuss our existing healthcare system’s reliance on blood draws for analysis, as well as the new CMM biosensors being developed by Nutromics that provide real-time molecular data to clinicians and patients.